drugset / Trial / NCT05653258

Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects

NCT05653258

RandomizedParallel-groupDouble-blindTreatment

Summary

All participants will undergo baseline biopsies of subcutaneous abdominal adipose tissue for cellular/molecular profiling via snRNA-seq and metabolic/physiological assessments (insulin sensitivity, glucose tolerance, and β-cell function). Older obese participants will be randomized into three arms: lifestyle intervention (n=24), senolytics (n=24), or placebo (n=24).

Timeline

Start
2023-10-17
Primary completion
2027-02-01
Completion
2028-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Quercetin Small molecule 1000 mg
Subject dasatinib anhydrous Small molecule 100 mg

Indications